Ladenburg Thalmann analyst Aydin Huseynov downgrades NextCure (NASDAQ:NXTC) from Buy to Neutral.
Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Shares of AppLovin Corporation (NASDAQ:APP) rose sharply in today’s pre-market trading after the company reported better-than-expected first-quarter financial…